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Introduction
Oral candidiasis is the most common human fungal infection. It 
is caused by an overgrowth of Candida that can lead to local dis-
comfort, taste alterations, and dysphagia from esophageal over-
growth, resulting in poor nutrition, slow recovery and prolonged 
hospital stays.
The incidence varies depending on age and certain predispos-
ing factors. Risk factors include a high carbohydrate diet, drugs, 
impaired salivary gland function, dentures or a sign of systemic 
disease such as diabetes mellitus. Moreover, Candida albicans (C. 
albicans) causes at least 80% of oropharyngeal candidiasis (OPC) 
cases in patients with HIV/AIDS.1,2
A number of animal models of oral candidiasis involving 
immunosuppressive treatment have been described.3,4 Under nor-
mal conditions this fungal infection is not stable and is usually 
cleared within 10 d.5 A reliable and novel mouse model of OPC 
has recently been described by Solis et al.6 Mice were rendered 
susceptible to oral infection by injection with cortisone acetate 
and then inoculated by placing a swab saturated with C. albicans 
sublingually. By combining this model and a new in vivo imag-
ing technique, exploiting genetically engineered, luminescent 
C. albicans,7,8 we obtained unprecedented tools for longitudinal 
monitoring of the course of OPC in live animals. Furthemore, 
Doyle et al.9 described a method for real-time monitoring vaginal 
oropharyngeal Candida albicans (C. albicans) infection usually occurs in patients with altered cell-mediated immune 
response. Many animal models have been developed for studying the pathogenesis of disease. Here we describe a new 
model for real-time monitoring of oral candidiasis. Mice were rendered susceptible to oral candidiasis by injection with 
cortisone acetate. oral infection was performed by placing a swab saturated with genetically engineered bioluminescent 
strain of C. albicans sublingually. An in vivo imaging technique, exploiting stably trasformed C. albicans that costitutively 
express luciferase, was adopted. this novel longitudinal study represents a powerful tool to: (1) test real-time progression 
of infection, (2) identify the target site of C. albicans in specific organs, (3) evaluate the efficacy of antifungal therapies and 
(4) explore the spread of C. albicans from the local to systemic compartment in a new way.
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and systemic C. albicans infections by using strains transformed 
with the firefly luciferase gene. However, this methods, differ-
ently from our experimental approach, was unable to reveal 
hyphal cells. Moreover, no studies of OPC infection have been 
undertaken by using this model.
Results
C57BL/6 mice were left untreated or treated subcutaneously 
(s.c.) with cortisone acetate every two days starting at day -1 rela-
tive to infection. The infection was performed as described by 
Solis et al.6 and the course of OPC was monitored 1, 3, 6 and 8 
d after infection. One day after challenge the infection appeared 
to go through a bottleneck in which only a small number of 
C. albicans cells were evidenced in the oral cavity (Fig. 1A and 
B). No differences in fungal load were evidenced between the 
untreated mice and those treated with corticosteroids. A modest 
rise of fungal load, evaluated as photon emission, was observed 
3 d after infection only in mice treated with corticosteroids. A 
significant increase of oral fungal burden was observed 6 d post-
infection again in these mice only (p = 0.0448). The fungal load 
continued to rise through to the end of the monitoring period 
(day +8; p = 0.0355). Mice were killed on day 8 for humane 
reasons. Corticosteroid-untreated mice did not show a significant 
fungal load in any determination performed. As a consequence, 
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The histological analysis of the tongue, esophagus and stomach 
of corticosteroid-treated mice was performed 8 d after infection 
and compared with corticosteroid-untreated mice. No histological 
modifications were evident in the untreated animals (Fig. 4A–C, 
left panels). Conversely, corticosteroid-treated mice showed an 
extensive colonization of the epithelium of the dorsal surface of the 
tongue by numerous hyphae and blastospores, with consequent 
complete destruction of papillary architecture and hyperplastic 
mucosal reaction (Fig. 4A, right panels). The esophagus lumen 
appeared obstructed by a mass of yeasts and hyphae and inflam-
matory cells including polymorphonuclear leukocyte (PMNL), 
and micro abscesses with hyphae and hyperplastic reaction were 
evident in the mucosa (Fig. 4B, right panels). Stomach sections 
showed an ulcerative gastric lesion in the glandular mucosa near 
the cardium atrial fold with infiltrates of yeasts and inflammatory 
cells and large abscesses containing hyphae and blastospores in 
the submucosal area (Fig. 4C, right panels). A progressive decline 
of body weight, reaching a maximum after 8 d, was observed in 
cortisone treated mice with OPC. The decline of body weight was 
not observed in cortisone untreated and infected mice (Fig. 5).
in subsequent experiments the determinations were performed 
only in corticosteroid-treated mice.
Corticosteroid-treated and infected mice were also monitored 
by using the standard assessment of CFU in the tongue, esopha-
gus and stomach. Figure 2 shows that there are no differences 
between the CFU recovery 3 and 6 d after challenge, while a sig-
nificant increase of fungal load was observed 8 d post-infection. 
Given that the coelenterazine substrate was added sublingually 
and anesthetized mice were immediately imaged with IVIS sys-
tem, the substrate was not able to reach the pharynx, esophagus 
and stomach; as a consequence, we performed an ex vivo analy-
sis from infected animals. Ex vivo bioluminescence imaging 
of pharynx, esophagus and stomach was performed at various 
times. No bioluminescence was manifested 3 d after infection; 
however, 6 d post-infection a clear and well-defined biolumines-
cent signal was observed in the first tract of the pharynx and 
esophagus. The progression of infection was also monitored 8 
d after challenge and at this time we observed that C. albicans 
had also gained access to the lower part of the esophagus and the 
stomach (Fig. 3).
Figure 1. in vivo imaging of opC. Mice treated (+C) and not treated (-C) with cortisone acetate were infected with C. albicans gLUC59 (1 × 106/ml). 1, 3, 
6 and 8 d post-infection anesthetized mice were treated sublingually with 10 μl of coelenterazine (0.5 mg/ml) and imaged in the iViS-200tM imaging 
system. Data are from one of three experiments with similar results. total photon flux from oral areas in the images (roi) of each mouse was quantified 
with Living imager software package (A). the statistical significance of total photon flux from roi was evaluated with the Student’s t test. p = 0.0448 
(day +6 post challenge vs day +1); p = 0.0355 (day +8 post challenge vs day +1) (B).
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assessed, (3) it allows the monitoring of C. albicans dissemina-
tion from the oral cavity to the gastrointestinal tract and (4) it 
decreases the need to sacrifice a large number of animals. Hence, 
this novel method provides a flexible and efficient approach to the 
real-time monitoring of oral candidiasis in live animals and will 
undoubtedly facilitate the evaluation of fungal and host param-
eters in the study of severity of infection in specific tissues.
Methods
C. albicans strain and culture. C. albicans CA1398 carrying 
the ACT1p-gLUC59 fusion (gLUC59) and C. albicans CA1399 
that did not express gLUC59 (control strain) were used.7 The 
gLUC59 luciferase reporter has previously been described.7 C. 
albicans gLUC59 and the control strain were cultured in YPD as 
described by Solis et al.6
Mouse model of OPC. Female, 6–8 weeks old, inbred 
C57BL/6 mice (Harlan Nossan Laboratories, Milan, Italy) were 
housed at the Animal Facilities of the University of Perugia. The 
procedures involving the animals and their care were conducted 
in conformity with the national and international laws and poli-
cies. Where indicated in the text, mice were treated with 225 
mg/kg cortisone acetate (Sigma-Aldrich) and all were infected 
by placing a calcium alginate swab (Fisher Scientific, Illkirch 
Cedex, France) saturated with 1 × 106/ml C. albicans suspension 
sublingually for 75 min as previously described.6 Infections were 
conducted under anesthesia with a s.c. injection of a mixture of 
Tiletamine:Zolazepam-Xylazine (50 mg/kg:5 mg/kg).
Real-time monitoring of OPC. At selected days post-
infection, starting 1 d after challenge, 10 μl (0.5 mg/ml in 
1:10 methanol:H
2
O) of coelenterazine (Synchem, OHM) was 
added sublingually. Mice were then imaged in the IVIS-200TM 
Imaging system (Xenogen Inc.) under s.c. anesthesia. The total 
photon emission from oral areas within the images (region of 
interest, ROI) of each mouse was quantified with Living ImageR 
software package. An ex vivo analysis of infected pharynx, 
Discussion
With this model we describe a new approach for longitudinal 
monitoring of the dynamics of oral C. albicans infection in 
C57BL/6 mice. C57BL/6 is the most widely used inbred strain 
and it provides a permissive background for maximal expres-
sion of most mutations. Recently, by using mice with C57BL/6 
background it has been discovered that Th17-deficient mice, 
which lack either interleukin (IL)-23p19 or the IL-17 receptor, 
are susceptible to OPC without additional immunosuppres-
sion.4 Notably, in our experimental system CFU recovery from 
the tongue 6 d after infection did not show a significant increase 
with respect to the level observed 3 d after infection; conversely, 
when the fungal load was measured by photon emission, a signifi-
cant increase was detected 6 d after challenge compared with 1 
d after infection. The discrepancy between the two methods was 
not observed when the fungal load was measured 8 d post chal-
lenge. At this time both methods evidenced an increased growth 
of C. albicans with respect to the first post challenge determina-
tion. Moreover, an ex vivo analysis demonstrated that 6 d post-
infection a clear and well-defined bioluminescent signal was 
observed, and at 8 d post challenge C. albicans had also gained 
access to the lower part of the esophagus and the stomach. This 
suggests that determination of fungal burden by measurement 
of photon emission permits a more rapid and sensitive evalua-
tion of infection than standard CFU counting. A possible expla-
nation is that the increase of fungal load which is detectable in 
the whole oral mucosa 6 d after infection is not appreciable with 
the standard assessment of CFUs from the tongue.6 Since the 
oral mucosa includes the tongue, gingiva, soft palate and phar-
ynx, CFU determination might not be completely accurate for 
expressing the real fungal load of the whole oral cavity. Indeed, a 
previous study has shown a consistent colonization of C. albicans 
in gingival tissues.10 In addition it has been reported that CFU 
of C. albicans in cell suspensions or homogenates prepared from 
infected tissues are not always accurate indicators of the severity 
of infection in mucosal tissues.11 An additional explanation of the 
observed discrepancy between the traditional CFU test and this 
novel method could be the ability of bioluminescence to assess 
hyphae7,12 that are critical for the invasion process,13,14 but might 
not be accurately determined by the CFU method.
The extent of disease was also determined by the histological 
analysis of the infected tongue, esophagus and stomach, demon-
strating the hyphal penetration into the deep layer of the tissue 
and the accumulation of leukocytes around the infecting organ-
isms. Another method for estimating disease severity is moni-
toring individual mice for weight loss. We have found that it is 
correlated with the progression of the disease.
In conclusion, our original combination of Solis et al.’s model 
of OPC and the gLUC59 reporter represents a powerful tool for 
several reasons: (1) it gives an accurate estimation of the Candida 
load in the whole oral cavity, including the load of invasive 
hyphae, (2) it allows for the longitudinal monitoring of oral can-
didiasis in individual animals, providing a unique possibility to 
determine the progression or resolution of OPC in real-time and 
avoiding individual variations when the time course of CFU is 
Figure 2. fungal burden in target organs. fungal burden of cortisone 
acetate treated mice with opC was evaluated 3, 6 and 8 d post-infection 
in tongue, esophagus and stomach. *p < 0.05 (day +8 post challenge vs 
day +3) according to Mann-Whitney U test.
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serial dilutions of organ homogenates onto YPD agar plus chlor-
amphenicol (50 μg/ml) (both from Sigma-Aldrich) and count-
ing CFUs. The disease severity was also evaluated by monitoring 
individual mice for weight loss.
Histological analysis. Eight days post-infection we analyzed 
tongue, esophageal and stomach tissues for pathological signs. 
The tissues were excised and fixed immediately in 10% formalin 
and successively embedded in paraffin. The tongues and stom-
achs were sectioned longitudinally to verify the extension of the 
lesions, the esophagi were sectioned transversally. The 3–5 μm 
thick sections were stained using the periodic acid-Schiff (PAS) 
esophagus and stomach from mice with OPC was performed. 
After 3, 6 and 8 d post-infection mice were euthanized, the 
gastric tracts (pharynx, esophagus and stomach) were excised 
and 10 μl (0.5 mg/ml) of coelenterazine (Synchem) was injected 
through the pharynx into the esophagus lumen, to visualize 
the fungal burden using the IVIS-200TM Imaging system as 
described above. None of the mice exhibited detectable carriage 
of oral C. albicans based on an oral swab taken before the first 
infection.
CFU assay. The fungal burden of the tongue, esophagus and 
stomach 3, 6 and 8 d post-infection was evaluated by plating 
Figure 3. ex vivo analysis of target organs. ex vivo analysis of infected pharynx, esophagus and stomach from cortisone acetate treated mice with 
opC was shown. 3, 6 and 8 d post-infection, mice were euthanized, gastric tracts were excised and 10 μl of coelenterazine (0.5 mg/ml) were injected 
through the pharynx into esophagus lumen to visualize the fungal burden and localization by the iViS-200tM imaging system. Data are from one of 
three experiments with similar results. roi was quantified with Living imager software package.
Figure 4. Histopathology. the tissue sections from non-cortisone treated (-C) and cortisone treated (+C) mice were shown. tongue (A, left panels), 
esophagus (B, left panels) and stomach (C, left panels) sections from non-cortisone treated mice did not show signs of fungal burden or mucosal 
modification; conversely, tongue (A, right panels) section of cortisone treated mice showed yeasts, hyphae (arrows) and blastoconidial forms (asterisk) 
that invade the whole superficial layer of dorsal and ventral surfaces of the organ, completely destroying the papillary architecture (dorsal). extensive 
hyperplastic reaction of spinous layer (acantosis) and aggregates of pMNL are evident. the lumen of esophagus (B, right panels) appeared obstructed 
by masses of fungi (arrows), inflammatory cells, and keratin; enlarged views show micro abscesses with hyphae (arrows) and hyperplastic mucosal 
reaction. finally, in the stomach (C, right panels) ulcerative lesions (red arrows) in the cardium atrial fold with massive infiltrates of inflammatory cells 
(mononuclear cells and rare pMNL), hyphae, blastospore (asterisk), large abscesses (yellow arrows) of inflammatory cells and candidal burden (arrows) 
are evident in the submucosal area under lamina propria. Scale bars are in μm. Data are representative of two mice and nine tissue sections for treat-
ment.
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procedure to visualize fungi, and examined by light microscopy 
(Leica DM2500). The scale bars are in μm.
Statistical analysis. The data are reported as the mean ± 
s.e.m. from triplicate samples of three experiments. The photon 
flux emission was compared using Student’s t test. CFU counts 
and weight loss were compared using Mann-Whitney U test. A 
value of p < 0.05 was considered significant.
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